Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?

PCV-21 was recently approved by the FDA and supported by ACIP. At this early stage (August 2024), CDC has not finalized guidance on PCV-21, so we do not know how the vaccine schedule will be changed.

An important distinction is that PCV-21 covers different serotypes of pneumococcus, as outlined in t...

PCV21 recently recommended by CDC and ACIP = NEW INFO: PCV21 is recommended for all adults 50 and older, and for those 19 and older with special risk factors...

The CDC now recommends PCV21, PCV20, or PCV15 (+PPSV23 a year later if got PCV15) to "all adults 50 years or older":

https://www.cdc.gov/pne...